top of page
Guangdong-Hong Kong-Macao Greater Bay Area International Research Platform
for Aptamer-based Translational Medicine and Drug Discovery (HKAP)
Therapeutic aptamer
No. | Principle Investigator(s) | Title | Project ID (Funding Body) |
|---|---|---|---|
1 | Dr. Yuanyuan Yu | Development of nucleic aptamer against sclerostin for osteoporosis therapy ( 2017.1.1-2019.12.31, RMB180,000) | NSFC 81601929 (NSFC) |
2 | Prof. Ge Zhang | Targeting sclerostin to reverse established osteoporosis: Aptamer characterization and evaluation for drug discovery (2017.1.1-2018.12.31, HK$1000,000) | UIM298 (ITF) |
3 | Dr. Baoting Zhang | Toward Reversing Established Osteoporosis: Synthesis and In Vitro Evaluation of a Bispecific Aptamer Targeting both Sclerostin and Dickkopf-1 (2018.1.1-2019.12.31, HK$1000,000) | UIM328 (ITF) |
bottom of page